SII to Apply for DCGI Approval for Covovax Trial on Children; Vaccine has Great Potential to Save Future Generation, Says CEO

Covovax is the second Covid-19 vaccine candidate, which is being developed and manufactured at Pune-based SII.

from Top India News- News18.com https://ift.tt/2U2UQcr
via IFTTT